Trial · NCT03563157
Results by group39
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 39
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Treatment-emergent Adverse Events (AEs) and Serious AEs (SAEs) | NANT Colorectal Cancer (CRC) Vaccine | Treatment Emergent Adverse Events | 2 | Participants | |
| Number of Participants With Treatment-emergent Adverse Events (AEs) and Serious AEs (SAEs) | NANT Colorectal Cancer (CRC) Vaccine | Treatment Emergent Serious Adverse Events | 1 | Participants | |
| Objective Response Rate by RECIST Version 1.1 and irRC | NANT Colorectal Cancer (CRC) Vaccine | 0 | Participants | ||
| Progression Free Survival by RECIST Version 1.1 and irRC | NANT Colorectal Cancer (CRC) Vaccine | RECIST | 6 | Full Range 5 to 7 | Months |
| Progression Free Survival by RECIST Version 1.1 and irRC | NANT Colorectal Cancer (CRC) Vaccine | irRC | 6 | Full Range 3 to 9 | Months |
| Overall Survival | NANT Colorectal Cancer (CRC) Vaccine | 8 | Full Range 7 to 9 | Months | |
| Disease Control Rate (Confirmed Complete Response, Partial Response, or Stable Disease Lasting for at Least 2 Months) by RECIST Version 1.1. | NANT Colorectal Cancer (CRC) Vaccine | Confirmed CR | 0 | Participants | |
| Disease Control Rate (Confirmed Complete Response, Partial Response, or Stable Disease Lasting for at Least 2 Months) by RECIST Version 1.1. | NANT Colorectal Cancer (CRC) Vaccine | Confirmed PR | 0 | Participants | |
| Disease Control Rate (Confirmed Complete Response, Partial Response, or Stable Disease Lasting for at Least 2 Months) by RECIST Version 1.1. | NANT Colorectal Cancer (CRC) Vaccine | Stable Disease | 2 | Participants | |
| Disease Control Rate (Confirmed Complete Response, Partial Response, or Stable Disease Lasting for at Least 2 Months) by RECIST Version 1.1. | NANT Colorectal Cancer (CRC) Vaccine | Progressive Disease | 0 | Participants | |
| Quality of Life by Patient Reported Outcomes (PRO) | NANT Colorectal Cancer (CRC) Vaccine | Physical Well-Being - Baseline | 19 | Full Range 11 to 27 | score on a scale |
| Quality of Life by Patient Reported Outcomes (PRO) | NANT Colorectal Cancer (CRC) Vaccine | Physical Well-Being - C2D8 | 24 | Full Range 24 to 24 | score on a scale |
| Quality of Life by Patient Reported Outcomes (PRO) | NANT Colorectal Cancer (CRC) Vaccine | Physical Well-Being - C5D1 | 17 | Full Range 17 to 17 | score on a scale |
| Quality of Life by Patient Reported Outcomes (PRO) | NANT Colorectal Cancer (CRC) Vaccine | Physical Well-Being - Unscheduled | 5 | Full Range 5 to 5 | score on a scale |
| Quality of Life by Patient Reported Outcomes (PRO) | NANT Colorectal Cancer (CRC) Vaccine | Physical Well-Being - End of treatment | 13 | Full Range 7 to 19 | score on a scale |
| Quality of Life by Patient Reported Outcomes (PRO) | NANT Colorectal Cancer (CRC) Vaccine | Social/Family Well-Being - Baseline | 21 | Full Range 19 to 22 | score on a scale |
| Quality of Life by Patient Reported Outcomes (PRO) | NANT Colorectal Cancer (CRC) Vaccine | Social/Family Well-Being - C2D8 | 15 | Full Range 15 to 15 | score on a scale |
| Quality of Life by Patient Reported Outcomes (PRO) | NANT Colorectal Cancer (CRC) Vaccine | Social/Family Well-Being - C5D1 | 16 | Full Range 16 to 16 | score on a scale |
| Quality of Life by Patient Reported Outcomes (PRO) | NANT Colorectal Cancer (CRC) Vaccine | Social/Family Well-Being - Unscheduled | 17 | Full Range 17 to 17 | score on a scale |
| Quality of Life by Patient Reported Outcomes (PRO) | NANT Colorectal Cancer (CRC) Vaccine | Social/Family Well-Being - End of treatment | 19 | Full Range 15 to 22 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03563157/results